Funding, launches, leadership moves and hiring signals across the companies building the future of science and healthcare.
Choose a market to see its news feed and every edition of its newsletter.
Lab and R&D software, scientific data platforms, LIMS/ELN, AI for drug discovery and biotech SaaS.
Contract development, manufacturing and research organisations: capacity, consolidation and clinical services.
Emerging and clinical-stage biotech: financings, readouts, regulatory milestones and C-suite moves.
Genomics, molecular diagnostics, liquid biopsy, digital pathology and precision medicine.
Healthcare AI, revenue cycle management, prior authorisation and payer/provider technology.
Materials informatics, cheminformatics and R&D software for chemicals, CPG and advanced materials.
Hiring trends, layoffs, applicant markets, salary data and what’s working in talent acquisition across life sciences.
Headlines from across the division.
They join the push to speed up prior authorization and make it more transparent by 2027. Big Tech is moving into payer workflows.
Read the source →27 companies cut 2,568 people, about 90% fewer than a year ago and the lowest quarter since BioSpace started tracking. New Jersey was hit hardest.
Read the source →Agents now run whole R&D workflows, with scientists approving key steps. Benchling calls agents its fastest-growing product.
Read the full story →A CMS deputy administrator said “a lot of things” about the AI-assisted Medicare prior auth pilot running in six states are not working. Expect more scrutiny of AI-led denials.
Read the source →Tango is cutting 14%, mostly research staff. EyePoint is halving its workforce, Foghorn is cutting 40%, and GSK plans 1,200+ cuts in Belgium.
Read the source →AI turns plain-English SOPs into GxP-ready workflows from research to production, shipping in December.
Read the source →Its ambient AI now links clinical documentation to financial workflows, and it works with 250+ healthcare organisations.
Read the source →GSK is putting $800M into biologics production in Pennsylvania, creating 300+ jobs.
Read the source →Drug-programme coordination agents are being folded into OpenAI’s Rosalind life sciences suite. The AI labs are now chasing R&D software budgets.
Read the source →Brellium raises $23M for AI that checks documentation before billing. It's expanding beyond behavioural health.
Read the source →Biopharma postings have risen for three quarters in a row, and biotech R&D postings were up 42% year on year in June.
Read the source →The chemistry R&D platform grew users 6x year on year, with customers including BASF, Henkel and Clorox.
Read the source →A three-minute weekly read: funding, launches, leadership moves and what they mean for hiring. No spam, one-click unsubscribe.
